C, T., AD, S., R, S., P, T., DA, P., & P, O. (2026). How flaws in study design and lead-time bias could affect the interpretation of data - Authors' reply. The Lancet. Oncology, 27(5), e235. https://doi.org/10.1016/S1470-2045(26)00125-7
Chicago Style (17th ed.) CitationC, Tang, Sherry AD, Sun R, Tran P, Palma DA, and Ost P. "How Flaws in Study Design and Lead-time Bias Could Affect the Interpretation of Data - Authors' Reply." The Lancet. Oncology 27, no. 5 (2026): e235. https://doi.org/10.1016/S1470-2045(26)00125-7.
MLA (9th ed.) CitationC, Tang, et al. "How Flaws in Study Design and Lead-time Bias Could Affect the Interpretation of Data - Authors' Reply." The Lancet. Oncology, vol. 27, no. 5, 2026, p. e235, https://doi.org/10.1016/S1470-2045(26)00125-7.